Picture loading failed.

Anti-EPCAM therapeutic antibody (Pre-made Edrecolomab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Edrecolomab (MAb17-1A, trade name Panorex) is a mouse-derived monoclonal antibody targeting the cell-surface glycoprotein EpCAM (17-1A), which is expressed on epithelial tissues and on various carcinomas.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-165-1mg 1mg 3090
GMP-Bios-ab-165-10mg 10mg 21890
GMP-Bios-ab-165-100mg 100mg 148000
GMP-Bios-ab-165-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-EPCAM therapeutic antibody (Pre-made Edrecolomab biosimilar,Whole mAb)
INN Name Edrecolomab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG2a
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved (w)
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed1995
Year Recommended1996
CompaniesAjinomoto;Centocor Inc
Conditions ApprovedColorectal cancer
Conditions Activena
Conditions DiscontinuedAdenocarcinoma;Pancreatic cancer
Development Techna